86
Views
12
CrossRef citations to date
0
Altmetric
Original Research

Bioequivalence of oxymorphone extended release and crush-resistant oxymorphone extended release

, , &
Pages 455-463 | Published online: 31 Oct 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (12)

Robert B. Raffa, Robert Colucci & Joseph V. Pergolizzi. (2017) The effects of food on opioid-induced nausea and vomiting and pharmacological parameters: a systematic review. Postgraduate Medicine 129:7, pages 698-708.
Read now
Stephen J Farr, Cynthia Y Robinson & Christopher M Rubino. (2015) Effects of food and alcohol on the pharmacokinetics of an oral, extended-release formulation of hydrocodone in healthy volunteers. Clinical Pharmacology: Advances and Applications 7, pages 1-9.
Read now
Paul Sloan. (2014) Update on extended-release opioids in pain management. Expert Opinion on Drug Delivery 11:2, pages 155-158.
Read now
Charles E Argoff, Steven P Stanos & Matthew S Wieman. (2013) Validity testing of patient objections to acceptance of tamper-resistant opioid formulations. Journal of Pain Research 6, pages 367-373.
Read now
Michael J Brennan. (2013) Update on prescription extended-release opioids and appropriate patient selection. Journal of Multidisciplinary Healthcare 6, pages 265-280.
Read now
David E Moody. (2013) Metabolic and toxicological considerations of the opioid replacement therapy and analgesic drugs: methadone and buprenorphine. Expert Opinion on Drug Metabolism & Toxicology 9:6, pages 675-697.
Read now
Jeffrey A. Gudin. (2013) Assessment of Extended-Release Opioid Analgesics for the Treatment of Chronic Pain. Journal of Pain & Palliative Care Pharmacotherapy 27:1, pages 49-61.
Read now
Laura M Lourenço, Michele Matthews & Robert N Jamison. (2013) Abuse-deterrent and tamper-resistant opioids: how valuable are novel formulations in thwarting non-medical use?. Expert Opinion on Drug Delivery 10:2, pages 229-240.
Read now
Eugene R. Viscusi. (2012) A Response to Seed et al, Regarding Choices of New Opioid Formulations. Hospital Practice 40:4, pages 64-65.
Read now
Marco Pappagallo & Marta Sokolowska. (2012) The Implications of Tamper–Resistant Formulations for Opioid Rotation. Postgraduate Medicine 124:5, pages 101-109.
Read now
Johannes H Bartholomaeus, Elisabeth Arkenau-Marić & Eric Galia. (2012) Opioid extended-release tablets with improved tamper-resistant properties. Expert Opinion on Drug Delivery 9:8, pages 879-891.
Read now